IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q4 2024 Holdings

Filed 2025-02-12 | 15 holdings | $281.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$166.5M6,068,12559.1%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$51.8M1,115,35218.4%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$13.6M1,025,0004.8%
Monte Rosa Therapeutics Inc (Glue)(GLUE)COM61225M102$10.2M1,472,3313.6%
Poseida Therapeutics Inc. (Pstx)(PSTXUSD)COM73730P108$10.0M1,043,2673.6%
Bicara Therapeutics Inc. (Bcax)(BCAX)COM055477103$9.9M568,9193.5%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$6.8M2,541,0092.4%
Compass Pathways Plc (Cmps)(CMPS)SPONSORED ADS20451W101$3.6M964,5001.3%
Biomea Fusion Inc (Bmea)(BMEA)COM09077A106$3.1M798,7571.1%
CalciMedica, Inc. (Calc)(CALC)COM NEW38942Q202$1.8M521,1140.7%
Elevation Oncology Inc (Elev)COM28623U101$1.6M2,834,9100.6%
Aclaris Therapeutics Inc (Acrs)(ACRS)COM00461U105$1.1M434,4550.4%
Marker Therapeutics, Inc. (Mrkr)(MRKR)COM NEW57055L206$1.0M325,3700.4%
OnKure Therapeutics, Inc. (Okur)(OKUR)COM CL A68277Q105$762.0K88,6070.3%
Viracta Therapeutics Inc (Virx)COM92765F108$46.2K288,5710.0%